HomeALKEM • NSE
Alkem Laboratories Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 33.74B | 1.52% |
Operating expense | 14.96B | 8.29% |
Net income | 6.26B | 5.19% |
Net profit margin | 18.55 | 3.63% |
Earnings per share | 52.34 | -2.59% |
EBITDA | 7.39B | 4.74% |
Effective tax rate | 12.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.89B | -36.59% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 119.10B | — |
Shares outstanding | 119.57M | — |
Price to book | 5.32 | — |
Return on assets | — | — |
Return on capital | 12.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 6.26B | 5.19% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
₹5,116.00
Day range
₹5,053.00 - ₹5,139.50
Year range
₹4,407.05 - ₹6,439.90
Market cap
604.40B INR
Avg Volume
78.73K
P/E ratio
28.07
Dividend yield
0.83%
Primary exchange
NSE
About
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
Founded
1973
Headquarters
Website
Employees
17,432
